NIUM, a pioneering startup at the forefront of gut microbiome research and personalized nutrition, is proud to announce the successful closing of its Seed funding round. This critical milestone was achieved with the support of BeAngels as the lead investor, alongside Luxembourg Business Angel Network (LBAN) and a group of private investors. NIUM’s innovative platform…

In a recent interview with BioVox, Alberto Noronha, Ph.D., CEO of Luxembourg-based biotech startup NIUM, delves into the powerful connection between the gut microbiome and human health. As we face a modern era of overnutrition yet undernourishment, Noronha highlights the growing importance of understanding how our diet and various compounds impact the trillions of microbes…

We are excited to announce the successful conclusion of our stool collection project for microbiome analysis! A huge thank you to all the amazing volunteers who contributed to this important research. Your participation has been invaluable in helping us enhance our gut-on-a-chip platform. The overwhelming response, with double the expected donors, exceeded our expectations and…

We are thrilled to announce that NIUM has signed a second license agreement with the University of Luxembourg, further enhancing our cutting-edge platform technology. This milestone reflects our ongoing commitment to innovation and the power of collaboration. At NIUM, we believe partnerships are essential in driving advancements in microbiome research, personalized nutrition, and overall health.…